SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) remains a focal point as investors navigate a complex macro environment defined by geopolitical tensions, shifting Fed policy expectations, and significant sector rotation out of high-flying technology stocks. The community is actively debating the sustainability of current index valuations amidst concerns over rising interest rates, corporate capital expenditure cycles, and the potential impact of ongoing global conflicts on market stability.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is gaining attention as community members discuss a significant institutional rotation into healthcare, with many highlighting the stock's partnership with Walmart and the integration of BetterHelp as key drivers for long-term growth. Investors are actively debating the potential for a short squeeze, citing high short interest and deep-value metrics, while expressing skepticism regarding current leadership and the stock's historical price suppression.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is attracting significant attention as investors rotate into software leaders showing relative strength, with community sentiment fueled by expectations of continued cloud infrastructure demand and the stock's role in the AI-driven observability space. Traders are actively monitoring technical support levels and high-volume option flow, positioning the stock as a key indicator for broader software sector sentiment.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Block Inc is trending after the company announced a significant workforce reduction alongside a pivot toward AI-driven efficiency. Community members are actively debating whether the move reflects a necessary operational turnaround or a superficial attempt to appease investors by scapegoating AI for broader structural challenges.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm Holdings is attracting heavy attention as the stock experiences significant volatility and aggressive rotation, with traders debating whether its recent price action represents a major bottoming phase or further downside risk. The community is actively monitoring the fintech sector's response to interest rate signals and potential S&P 500 inclusion, while simultaneously navigating the ongoing battle between long-term growth bulls and those betting on a correction.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community debate following an earnings report that featured raised guidance and revenue growth alongside delays in key clinical trials, leaving investors divided over the stock's future. While some shareholders are actively celebrating the company's transition to profitability and aggressive share buybacks, others are expressing frustration over stagnant price action and are calling for more transparency from leadership.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The firm's solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Its customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. The firm's regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. Its customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is currently trending as investors focus on its strong enterprise software fundamentals, including a recent revenue and earnings beat, while the community remains hyper-focused on its potential S&P 500 inclusion and ongoing AI integration efforts. Market participants are actively debating the company's long-term competitive moat against CRM platforms and evaluating buy-in opportunities following recent price volatility.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

Investors are closely monitoring Chinese equities as the sector attempts to recover from a prolonged downtrend, with many participants debating the merits of long-term value accumulation versus geopolitical and regulatory risks. Sentiment is currently driven by discussions around massive options activity, expectations for domestic economic stimulus, and the sector's significant valuation discount relative to US-based technology assets.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors react to the project's v4 launch and a new revenue-sharing model that distributes decentralized GPU compute earnings to node runners and stakers. The community is highlighting a significant supply shock, noting that a large majority of the token supply is locked in long-term staking, leaving a limited float for new market participants.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is experiencing significant volatility as investors weigh strong battery storage growth and U.S. manufacturing expansion against concerns over debt levels and stagnant share price performance. The community remains deeply divided, with some investors accumulating shares in anticipation of a potential valuation re-rating, while others voice frustration over management's perceived lack of shareholder transparency and aggressive short selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medical Stocks To Research - January 9th

Eli Lilly and Company, Novo Nordisk A/S, Revolution Medicines, Thermo Fisher Scientific, UnitedHealth Group, Cidara Therapeutics, and Merck & Co., Inc. are the seven Medical stocks to watch today...

Biotech Stocks Worth Watching - January 8th

Cidara Therapeutics, Abivax, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded...

Merck to Complete Acquisition of Cidara Therapeutics

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all the outstanding shares of...

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Consensus Recommendation of "Hold" from Analysts

Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) has been assigned a consensus recommendation of "Hold" from the twelve brokerages that are presently covering the company, MarketBeat.com...

Biotech Stocks To Follow Now - January 5th

Amicus Therapeutics, Danaher, argenex, Cidara Therapeutics, United Therapeutics, Vertex Pharmaceuticals, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock...

Cidara Therapeutics (NASDAQ:CDTX) Hits New 12-Month High - Here's Why

Cidara Therapeutics (NASDAQ:CDTX) Sets New 1-Year High - Here's Why...

Promising Biotech Stocks To Consider - January 4th

Danaher, Vertex Pharmaceuticals, Cidara Therapeutics, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are...

Biotech Stocks To Watch Today - January 3rd

Danaher, Vertex Pharmaceuticals, Cidara Therapeutics, Moderna, United Therapeutics, argenex, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...

Top Biotech Stocks To Watch Now - January 2nd

Danaher, Moderna, and Cidara Therapeutics are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are publicly traded shares of companies that use...

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?

Key PointsHighVista Strategies initiated a position in Cidara Therapeutics, buying 70,904 shares valued at $6.79 million...

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover 

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CDTXCidara Therapeutics Inc

Fundamentals

Latest CDTX News